For help on how to get the results you want, see our search tips.
361 results
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Leganto
rotigotine, Restless Legs Syndrome; Parkinson Disease
Date of authorisation: 16/06/2011, Revision: 19, Withdrawn, Last updated: 18/02/2022 -
List item
Human medicine European public assessment report (EPAR): Raylumis
Tanezumab, Osteoarthritis; Pain
Date of refusal: 15/11/2021, Refused, Last updated: 15/02/2022 -
List item
Human medicine European public assessment report (EPAR): Staquis
Crisaborole, Dermatitis, Atopic
Date of authorisation: 27/03/2020,
, Revision: 6, Withdrawn, Last updated: 08/02/2022
-
List item
Human medicine European public assessment report (EPAR): Atripla
efavirenz, emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 13/12/2007, Revision: 36, Withdrawn, Last updated: 21/01/2022 -
List item
Human medicine European public assessment report (EPAR): Nouryant
Istradefylline, Parkinson Disease
Date of refusal: 06/01/2022, Refused, Last updated: 19/01/2022 -
List item
Human medicine European public assessment report (EPAR): Ytracis
yttrium (90Y) chloride, Radionuclide Imaging
Date of authorisation: 24/03/2003, Revision: 7, Withdrawn, Last updated: 19/01/2022 -
List item
Human medicine European public assessment report (EPAR): Pantoloc Control
pantoprazole, Gastroesophageal Reflux
Date of authorisation: 11/06/2009, Revision: 18, Withdrawn, Last updated: 18/01/2022 -
List item
Human medicine European public assessment report (EPAR): Docetaxel Teva
docetaxel, Head and Neck Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Prostatic Neoplasms; Stomach Neoplasms; Breast Neoplasms
Date of authorisation: 26/01/2010,
, Revision: 18, Withdrawn, Last updated: 14/12/2021
-
List item
Human medicine European public assessment report (EPAR): Pemetrexed Lilly
pemetrexed, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 14/09/2015,, Revision: 7, Withdrawn, Last updated: 26/11/2021
-
List item
Human medicine European public assessment report (EPAR): Equidacent
bevacizumab, Colorectal Neoplasms; Breast Neoplasms; Ovarian Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell
Date of authorisation: 24/09/2020,, 
, Revision: 3, Withdrawn, Last updated: 25/11/2021
-
List item
Human medicine European public assessment report (EPAR): Telmisartan Teva
telmisartan, Hypertension
Date of authorisation: 25/01/2010,, Revision: 11, Withdrawn, Last updated: 17/09/2021
-
List item
Human medicine European public assessment report (EPAR): Caspofungin Accord
caspofungin acetate, Candidiasis; Aspergillosis
Date of authorisation: 11/02/2016,, Revision: 6, Withdrawn, Last updated: 20/08/2021
-
List item
Human medicine European public assessment report (EPAR): Ritemvia
rituximab, Lymphoma, Non-Hodgkin; Microscopic Polyangiitis; Wegener Granulomatosis
Date of authorisation: 13/07/2017,, , Revision: 8, Withdrawn, Last updated: 16/08/2021
-
List item
Human medicine European public assessment report (EPAR): Lumoxiti
Moxetumomab pasudotox, Leukemia, Hairy Cell
Date of authorisation: 08/02/2021, Withdrawn, Last updated: 11/08/2021 -
List item
Human medicine European public assessment report (EPAR): Azacitidine Celgene
azacitidine, Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Leukemia, Myeloid, Acute
Date of authorisation: 02/08/2019, Revision: 2, Withdrawn, Last updated: 04/08/2021 -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Pfizer (previously known as Pemetrexed Hospira UK Limited)
pemetrexed ditromethamine, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 24/04/2017,, Revision: 7, Withdrawn, Last updated: 29/07/2021
-
List item
Human medicine European public assessment report (EPAR): Portrazza
necitumumab, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 15/02/2016,, Revision: 3, Withdrawn, Last updated: 27/07/2021
-
List item
Human medicine European public assessment report (EPAR): Ulipristal Acetate Gedeon Richter
ulipristal acetate, Leiomyoma
Date of authorisation: 27/08/2018, Revision: 1, Withdrawn, Last updated: 09/07/2021 -
List item
Human medicine European public assessment report (EPAR): Ribavirin Teva Pharma B.V.
Ribavirin, Hepatitis C, Chronic
Date of authorisation: 01/07/2009,, Revision: 14, Withdrawn, Last updated: 09/07/2021
-
List item
Human medicine European public assessment report (EPAR): Ribavirin Teva
Ribavirin, Hepatitis C, Chronic
Date of authorisation: 31/03/2009,, Revision: 15, Withdrawn, Last updated: 09/07/2021
-
List item
Human medicine European public assessment report (EPAR): Nodetrip (previously Xeristar)
duloxetine, Anxiety Disorders; Depressive Disorder, Major; Diabetic Neuropathies
Date of authorisation: 17/12/2004, Revision: 32, Withdrawn, Last updated: 22/06/2021 -
List item
Human medicine European public assessment report (EPAR): PegIntron
peginterferon alfa-2b, Hepatitis C, Chronic
Date of authorisation: 24/05/2000, Revision: 36, Withdrawn, Last updated: 03/06/2021 -
List item
Human medicine European public assessment report (EPAR): Gamifant
Emapalumab, Immune System Diseases
Date of refusal: 07/01/2021,
, Refused, Last updated: 23/03/2021
-
List item
Human medicine European public assessment report (EPAR): Truberzi
eluxadoline, Irritable Bowel Syndrome; Diarrhea
Date of authorisation: 19/09/2016,, Revision: 6, Withdrawn, Last updated: 25/02/2021
-
List item
Human medicine European public assessment report (EPAR): Prepandrix
A/Indonesia/05/2005 (H5N1) like strain used (PR8-IBCDC-RG2), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 14/05/2008,
, Revision: 13, Withdrawn, Last updated: 23/02/2021